Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kwekkeboom

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Clinical Endocrinology|February 1, 1992
Long-term treatment with the dopamine agonist CV 205-502 of patients with a clinically non-functioning, gonadotroph, or alpha-subunit secreting pituitary adenomaD J Kwekkeboom, S W Lamberts
World Journal of Surgery|February 1, 1996
Somatostatin receptor scintigraphy in patients with carcinoid tumorsD J Kwekkeboom, E P Krenning
European Radiology|August 25, 1997
Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overviewD J Kwekkeboom, E P Krenning
The Journal of Clinical Endocrinology and Metabolism|June 1, 1989
Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptineD J Kwekkeboom, F H de Jong, S W Lamberts
Journal of Steroid Biochemistry|October 1, 1989
Confounding factors in the interpretation of gonadotropin and gonadotropin-subunit release from cultured human pituitary adenomasD J Kwekkeboom, F H de Jong, S W Lamberts
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 1, 1998
Somatostatin receptors and breast cancerC H van Eijck, D J Kwekkeboom, E P Krenning
European Journal of Clinical Investigation|August 7, 1998
Chromogranin A: its clinical value as marker of neuroendocrine tumoursF R Nobels, D J Kwekkeboom, R Bouillon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Cost-effectiveness analysis of somatostatin receptor scintigraphyD J Kwekkeboom, S W Lamberts, J D Habbema, et al.
Archives of Dermatology|June 1, 1992
Somatostatin analogue scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastasesD J Kwekkeboom, A M Hoff, S W Lamberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 1999
Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptakeD J Kwekkeboom, P P Kooij, W H Bakker, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Clinical Endocrinology|February 1, 1992
Long-term treatment with the dopamine agonist CV 205-502 of patients with a clinically non-functioning, gonadotroph, or alpha-subunit secreting pituitary adenomaD J Kwekkeboom, S W Lamberts
World Journal of Surgery|February 1, 1996
Somatostatin receptor scintigraphy in patients with carcinoid tumorsD J Kwekkeboom, E P Krenning
European Radiology|August 25, 1997
Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overviewD J Kwekkeboom, E P Krenning
The Journal of Clinical Endocrinology and Metabolism|June 1, 1989
Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptineD J Kwekkeboom, F H de Jong, S W Lamberts
Journal of Steroid Biochemistry|October 1, 1989
Confounding factors in the interpretation of gonadotropin and gonadotropin-subunit release from cultured human pituitary adenomasD J Kwekkeboom, F H de Jong, S W Lamberts
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 1, 1998
Somatostatin receptors and breast cancerC H van Eijck, D J Kwekkeboom, E P Krenning
European Journal of Clinical Investigation|August 7, 1998
Chromogranin A: its clinical value as marker of neuroendocrine tumoursF R Nobels, D J Kwekkeboom, R Bouillon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Cost-effectiveness analysis of somatostatin receptor scintigraphyD J Kwekkeboom, S W Lamberts, J D Habbema, et al.
Archives of Dermatology|June 1, 1992
Somatostatin analogue scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastasesD J Kwekkeboom, A M Hoff, S W Lamberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 1999
Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptakeD J Kwekkeboom, P P Kooij, W H Bakker, et al.
Pageof 9